Leveraging advanced spatial proteomics, scientists have identified the JAK/STAT pathway as a critical target for treating toxic epidermal necrolysis, offering new hope for patients with this ...
Recently, the Food and Drug Administration (FDA) has approved Rinvoq for some people with atopic dermatitis. Rinvoq is a Janus kinase (JAK) inhibitor. These drugs work by blocking an important pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results